ranbaxy laboratories (GoldmanSachs) Potential US$1bn to settle FDA charges relating to Lipitor

Date Rating Target Price Recommendation Price Broker house
5 May 2011 neutral 495 453 GoldmanSachs Report

No comments:

Post a Comment